Trump-RFK Jr.’s FDA in science freefall: The leucovorin autism “cure” fiasco is one of many – Genetic Literacy Project
Trump-RFK Jr.’s FDA in science freefall: The leucovorin autism “cure” fiasco is one of many Genetic Literacy Project
Trump-RFK Jr.’s FDA in science freefall: The leucovorin autism “cure” fiasco is one of many Genetic Literacy Project
Two top aides to RFK Jr. leaving HHS as part of leadership shakeup CNN
Two top aides to RFK Jr. leaving HHS as part of leadership shakeup – CNN Read Post »
Here’s how a year of RFK, Jr., has changed American science Scientific American
Here’s how a year of RFK, Jr., has changed American science – Scientific American Read Post »
White House seeks to tighten control over HHS priorities with personnel shakeup CNN
White House seeks to tighten control over HHS priorities with personnel shakeup – CNN Read Post »
This review article examines the use of growth factors and the stable gastric pentadecapeptide BPC 157 for treating injuries to tendons, ligaments, muscles, and their associated junctions with bone. The authors synthesize evidence from multiple research domains showing that BPC 157 exhibits angiogenic, anti-inflammatory, and tissue-regenerative properties in preclinical models of musculoskeletal injury. The evidence base includes human clinical studies, animal models, and in vitro research, though this is a literature review rather than original research.
This case report documents a patient who developed persistent methemoglobinemia from unsupervised use of a topical dapsone-adapalene combination product, highlighting the risk of systemic absorption and adverse effects from unmonitored application of this dermatological agent. The patient’s methemoglobinemia was treated with methylene blue, demonstrating its effectiveness in reversing dapsone-induced oxidative damage to hemoglobin. This is a human clinical case report (low evidence level) that illustrates an important safety concern with topical dapsone use.
Persistent methaemoglobinaemia due to unsupervised use of topical dapsone-adapalene. Read Post »
What RFK Jr.’s Unproven Autism Treatment Could Mean for Autistic Patients and Their Families Gizmodo
Here’s why RFK, Jr.’s recommended Denmark’s vaccine policy is a lousy—and dangerous–model for the U.S. Genetic Literacy Project
This animal study found that GHK-Cu helps repair damaged fascia (connective tissue) by delivering copper to specific parts of cells where it’s needed. The copper activates enzymes that build collagen and promotes blood vessel formation, leading to better tissue healing. In rabbits with fascia injuries, this approach significantly improved tissue repair and regeneration.
This study found that NMN supplementation can reduce inflammation by blocking the release of inflammatory molecules from aging cells. When cells become senescent (aged and damaged), they normally secrete harmful inflammatory substances that contribute to chronic diseases and aging. NMN appears to prevent this inflammatory secretion by boosting cellular energy levels and activating protective proteins. This suggests NMN could help combat age-related inflammation and its associated health problems.
This research review examines how activating estrogen-related receptors (ERRα/β/γ) can mimic the beneficial effects of physical exercise at the molecular level. The study focuses on SLU-PP-332, a compound that targets these receptors to potentially provide exercise-like metabolic benefits for patients who cannot engage in regular physical activity. This pharmacological approach could help address chronic diseases linked to sedentary lifestyles by activating the same cellular pathways that exercise normally triggers. The research suggests promise for treating metabolic dysfunction in physically inactive patients.
This review article examined multiple classes of antiarrhythmic agents—including conventional Class I-IV antiarrhythmics, late sodium current inhibitors, potassium channel enhancers, ryanodine receptor stabilizers, gap junction modulators, atrial-selective agents, and the peptide BPC 157—and their proposed cytoprotective mechanisms in managing cardiac arrhythmias. The authors synthesized evidence suggesting these various drug classes may provide cardioprotection through different cellular pathways, though the review does not present new experimental data comparing efficacy. This is a **review article** synthesizing existing literature rather than original human clinical or experimental research.